Penetration and drug delivery of albumin nanoparticles into pancreatic multicellular tumor spheroids
Author:
Affiliation:
1. Centre for Advanced Macromolecular Design
2. School of Chemistry
3. University of New South Wales
4. Kensington
5. Sydney
6. Department of Surgery
7. St. George Hospital
8. Kogarah
9. Australia
10. School of Chemical Engineering
Abstract
Albumin-based nanoparticles have been exploited as a useful carrier for the efficient delivery of anti-cancer drugs.
Funder
Australian Research Council
Publisher
Royal Society of Chemistry (RSC)
Subject
General Materials Science,Biomedical Engineering,General Chemistry,General Medicine
Link
http://pubs.rsc.org/en/content/articlepdf/2017/TB/C7TB02902K
Reference62 articles.
1. Nanopreparations to overcome multidrug resistance in cancer
2. Multifunctional nanocarriers
3. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
4. How can nanomedicines overcome cellular-based anticancer drug resistance?
5. Delivering nanomedicine to solid tumors
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. GP60 and SPARC as albumin receptors: key targeted sites for the delivery of antitumor drugs;Frontiers in Pharmacology;2024-01-23
2. Feedback enhanced tumor targeting delivery of albumin-based nanomedicine to amplify photodynamic therapy by regulating AMPK signaling and inhibiting GSTs;Chinese Chemical Letters;2023-10
3. Challenges and opportunities in delivering oral peptides and proteins;Expert Opinion on Drug Delivery;2023-07-17
4. Advances and Prospects in the Treatment of Pancreatic Cancer;International Journal of Nanomedicine;2023-07
5. Predicting nanocarriers’ efficacy in 3D models with Brillouin microscopy;Nanoscale;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3